As on Monday, 4 October 2021, new investors like IIFL and Steadview Capital are discussing with PharmEasy to participate in its pre-IPO funding round. A US-based hedge fund has also shown interest to participate in the same and is currently in talks with the e-pharmacy. In addition, PharmEasy has confirmed a subsequent transaction of nearly …
The IPO market has been witnessing an upswing in FY2021-2022, not just in India but in markets across the world. In the first nine months of 2021, the global IPO market has managed to rake up a whopping $330.6 billion, of which Indian IPOs comprise about 3%. Following is a look at a few interesting …
Top medical devices manufacturer Sahajanand Medical Technologies (SMT) has filed its Draft Red Herring Prospectus (DRHP) with SEBI. The company aims to raise Rs. 1,500 crores through its initial public offering. As of now, SMT does not have any peers listed on the market. However, it is the second firm in the medical devices segment …
An Overview SEBI, the market regulator, stated on Tuesday to loosen the rules governing the issuance of shares with superior voting rights (SR shares), which will benefit new-age technology firms. According to the Securities and Exchange Board of India (SEBI), promoters with a net worth of more than Rs 1,000 crore can have superior voting …
Waaree Energies, a Mumbai-based solar module manufacturer, has filed its DRHP for initial public offering (IPO) comprising a fresh issue worth Rs. 1,350 crores. The issue will also have an OFS of 40,07,500 equity shares by promoters. The company intends to use around Rs. 978.36 crores to set up a 2 GW/year solar cell producing …
Healthcare chain Vijaya Diagnostics and specialty chemical manufacturer Ami Organics are ready to open for public subscription. Their respective public offer will open on 1 September and will conclude on 3 September. Collectively, these companies plan to raise nearly Rs. 2,465 crores via their public offer. Analysts believe that the IPO frenzy will keep the …
Infinion Biopharma has filed a DRHP with capital market regulatory body SEBI to go public. This initial public offering will include selling 45 lakh equity shares at a face value of Rs. 10 per share. Besides the public issue, Infinion Biopharma is also considering a pre-IPO placement of 7 lakh shares. Furthermore, Aryaman Financial Services …
By the closing date on 3 September 2021, Vijaya Diagnostic IPO was subscribed 4.54 times and received bids for 11,36,44,020 shares. The IPO’s issue size was Rs. 1,895 crores. This IPO comprises entirely of an offer for sale, as per its DRHP. Day 3 Subscription Status of Vijaya Diagnostic IPO Given below is Vijaya Diagnostic IPO …
At the end of the third day, Ami Organics’ IPO received a total subscription of 64.54 times, receiving 42,22,36,296 bids for its shares. The IPO issue size here is worth Rs. 569.64 crores. As per the DRHP, it includes fresh issue shares of up to Rs. 200 crores and an OFS of Rs. 369.64 crores. …
Investors could witness WAPCOS’s initial public offer by the end of March. As per reports, the Department of Investment and Public Asset Management or DIPAM had floated tenders in February. The said tenders were to engage a registrar and an advertising firm to sell a nearly 25% stake in WAPCOS via a public offer. WAPOS …
